A new trading day began on Friday, with Compass Therapeutics Inc (NASDAQ: CMPX) up 4.18% from the previous day of trading, before settling in for the closing price of $4.07. CMPX’s price has ranged from $1.27 to $4.09 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -104.70% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -50.17%. With a float of $109.99 million, this company’s outstanding shares have now reached $138.28 million.
Compass Therapeutics Inc (CMPX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Compass Therapeutics Inc is 35.89%, while institutional ownership is 43.14%. The most recent insider transaction that took place on May 27 ’25, was worth 21,100. In this transaction CHIEF EXECUTIVE OFFICER of this company bought 10,000 shares at a rate of $2.11, taking the stock ownership to the 6,480,825 shares. Before that another transaction happened on Apr 09 ’25, when Company’s Director sold 3,571,428 for $1.59, making the entire transaction worth $5,678,571. This insider now owns 0 shares in total.
Compass Therapeutics Inc (CMPX) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.08 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -50.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.92% during the next five years compared to -104.70% drop over the previous five years of trading.
Compass Therapeutics Inc (NASDAQ: CMPX) Trading Performance Indicators
Here are Compass Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.55 in one year’s time.
